A pain-induced tonic hypodopaminergic state augments phasic dopamine release in the nucleus accumbens.
Journal
Pain
ISSN: 1872-6623
Titre abrégé: Pain
Pays: United States
ID NLM: 7508686
Informations de publication
Date de publication:
10 2020
10 2020
Historique:
pubmed:
27
5
2020
medline:
20
3
2021
entrez:
27
5
2020
Statut:
ppublish
Résumé
Diseases and disorders such as Parkinson disease, schizophrenia, and chronic pain are characterized by altered mesolimbic dopaminergic neurotransmission. Dopamine release in the nucleus accumbens influences behavior through both tonic and phasic signaling. Tonic dopamine levels are hypothesized to inversely regulate phasic signals through dopamine D2 receptor feedback inhibition. We tested this hypothesis directly in the context of ongoing pain. Tonic and phasic dopamine signals were measured using fast-scan controlled-adsorption voltammetry and fast-scan cyclic voltammetry, respectively, in the nucleus accumbens shell of male rats with standardized levels of anesthesia. Application of capsaicin to the cornea produced a transient decrease in tonic dopamine levels. During the pain-induced hypodopaminergic state, electrically evoked phasic dopamine release was significantly increased when compared to baseline, evoked phasic release. A second application of capsaicin to the same eye had a lessened effect on tonic dopamine suggesting desensitization of TRPV1 channels in that eye. Capsaicin treatment in the alternate cornea, however, again produced coincident decreased dopaminergic tone and increased phasic dopamine release. These findings occurred independently of stimulus lateralization relative to the hemisphere of dopamine measurement. Our data show that (1) the mesolimbic dopamine circuit reliably encodes acute noxious stimuli; (2) ongoing pain produces decreases in dopaminergic tone; and (3) pain-induced decreases in tonic dopamine correspond to augmented evoked phasic dopamine release. Enhanced phasic dopamine neurotransmission resulting from salient stimuli may contribute to increased impulsivity and cognitive deficits often observed in conditions associated with decreased dopaminergic tone, including Parkinson disease and chronic pain.
Identifiants
pubmed: 32453137
doi: 10.1097/j.pain.0000000000001925
pmc: PMC7508893
mid: NIHMS1594582
pii: 00006396-202010000-00018
doi:
Substances chimiques
Receptors, Dopamine D2
0
Dopamine
VTD58H1Z2X
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
2376-2384Subventions
Organisme : NIDA NIH HHS
ID : R01 DA041809
Pays : United States
Organisme : NIGMS NIH HHS
ID : R25 GM062584
Pays : United States
Organisme : NIGMS NIH HHS
ID : T32 GM008804
Pays : United States
Références
J Neurosci. 2016 Jan 06;36(1):98-112
pubmed: 26740653
J Neurosci. 2004 May 5;24(18):4393-400
pubmed: 15128853
Drug Alcohol Depend. 1995 Feb;37(2):111-29
pubmed: 7758401
Arch Clin Neuropsychol. 2009 Feb;24(1):113-22
pubmed: 19395361
Neuropharmacology. 2015 Oct;97:383-93
pubmed: 26113399
Front Psychol. 2014 Nov 12;5:1301
pubmed: 25429278
J Pain. 2014 May;15(5):457-67
pubmed: 24365324
Schizophr Bull. 2009 May;35(3):549-62
pubmed: 19325164
J Biol Chem. 2012 Jun 1;287(23):19462-71
pubmed: 22493457
Eur J Pain. 2008 Oct;12(7):866-9
pubmed: 18226937
Pain. 2015 Jan;156(1):175-184
pubmed: 25599313
Trends Neurosci. 2015 Nov;38(11):741-750
pubmed: 26603560
Front Neurosci. 2012 Sep 25;6:137
pubmed: 23055953
Clin Chem. 2003 Oct;49(10):1763-73
pubmed: 14500617
Pain. 2014 Aug;155(8):1659-1666
pubmed: 24861580
eNeuro. 2017 Jun 7;4(3):
pubmed: 28593190
Curr Opin Pharmacol. 2009 Feb;9(1):53-8
pubmed: 19138563
Langmuir. 2013 Dec 3;29(48):14885-92
pubmed: 24245864
Neuropsychopharmacology. 2011 Jan;36(1):114-32
pubmed: 20881944
Korean J Pain. 2018 Apr;31(2):116-124
pubmed: 29686810
J Neurosci. 1997 Nov 1;17(21):8580-7
pubmed: 9334429
Invest Ophthalmol Vis Sci. 2018 Jul 2;59(8):3739-3746
pubmed: 30046815
Proc Natl Acad Sci U S A. 2009 Mar 24;106(12):4894-9
pubmed: 19261850
Pain. 2003 Nov;106(1-2):43-8
pubmed: 14581109
Neuroscience. 2014 Dec 12;282:13-22
pubmed: 24463000
Neuropsychopharmacology. 2014 Feb;39(3):614-24
pubmed: 24008352
Anal Chem. 2015 Mar 3;87(5):2600-7
pubmed: 25692657
Pain. 2017 Aug;158(8):1408-1416
pubmed: 28715349
Med Hypotheses. 2004;62(3):420-4
pubmed: 14975515
Pain Res Manag. 2018 Jul 18;2018:5457870
pubmed: 30123398
J Nucl Med. 2012 Dec;53(12):1916-25
pubmed: 23143086
Pain. 2003 Jan;101(1-2):149-54
pubmed: 12507709
Neuropharmacology. 2014 Jan;76 Pt B:351-9
pubmed: 23578393
Pain. 2016 Jun;157(6):1194-1198
pubmed: 26797678
Neuroscience. 2016 Dec 3;338:81-92
pubmed: 27189881
Nat Neurosci. 2016 Feb;19(2):220-2
pubmed: 26691834
Curr Opin Chem Biol. 2013 Oct;17(5):860-7
pubmed: 23856056
J Neurochem. 2002 Aug;82(4):721-35
pubmed: 12358778
Ann N Y Acad Sci. 2013 Apr;1282:1-11
pubmed: 23496247
Neuroscientist. 2001 Aug;7(4):293-302
pubmed: 11488395
J Abnorm Psychol. 2010 Feb;119(1):50-59
pubmed: 20141242
Transl Psychiatry. 2013 Dec 17;3:e337
pubmed: 24346135
Anal Chem. 2008 Jun 1;80(11):4040-8
pubmed: 18433146
Mov Disord. 2009 Aug 15;24(11):1561-70
pubmed: 19526584
Science. 2004 Mar 26;303(5666):2040-2
pubmed: 15044807
Pain. 2009 Jan;141(1-2):173-7
pubmed: 19100686
Neuroscience. 2012 Jul 26;215:42-58
pubmed: 22542672
Neurosci Lett. 2006 Jan 16;392(3):159-64
pubmed: 16257488
Eur J Neurosci. 2007 Jun;25(12):3576-82
pubmed: 17610577
J Neurophysiol. 2013 Sep;110(5):1221-6
pubmed: 23785130
ACS Chem Neurosci. 2015 Nov 18;6(11):1802-12
pubmed: 26322962
Arch Intern Med. 2003 Nov 10;163(20):2433-45
pubmed: 14609780
Pain. 2004 Mar;108(1-2):129-36
pubmed: 15109516
Ageing Res Rev. 2017 May;35:74-86
pubmed: 28179128
Exp Clin Psychopharmacol. 1999 Aug;7(3):187-97
pubmed: 10472506
ACS Chem Neurosci. 2017 Feb 15;8(2):221-234
pubmed: 28127962
Neurosci Lett. 2016 Aug 26;629:73-78
pubmed: 27369326
Neuroscience. 2012 Jan 10;201:331-7
pubmed: 22108611
Mov Disord. 2008 Feb 15;23(3):411-5
pubmed: 18067187
Front Neuroanat. 2014 Dec 15;8:155
pubmed: 25565980
J Neurosci. 2013 Oct 9;33(41):16383-93
pubmed: 24107968
Brain Cogn. 1982 Jan;1(1):71-83
pubmed: 6927555
Neuron. 2010 Apr 15;66(1):149-60
pubmed: 20399736
J Neurochem. 2009 Sep;110(5):1491-501
pubmed: 19627437
Nat Neurosci. 2003 Sep;6(9):968-73
pubmed: 12897785
J Psychoactive Drugs. 2012 Apr-Jun;44(2):119-24
pubmed: 22880539
Neuroscience. 2009 Jul 7;161(3):671-9
pubmed: 19362121
Chem Commun (Camb). 2015 Feb 11;51(12):2235-8
pubmed: 25249291